{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:40:01Z","timestamp":1777959601961,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.yebeh.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T10:32:33Z","timestamp":1497090753000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Folic acid use by women with epilepsy: Findings of the Epilepsy Birth Control Registry"],"prefix":"10.1016","volume":"72","author":[{"given":"Andrew G.","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devon B.","family":"MacEachern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah B.","family":"Mandle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn E.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Allen Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2017.05.007_bb0005","first-page":"52","article-title":"Folic acid supplementation and pregnancy: more than just neural tube defect prevention","volume":"4","author":"Greenberg","year":"2011","journal-title":"Rev Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.yebeh.2017.05.007_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/1471-0528.12116","article-title":"Preconception health care and congenital disorders: mathematical modelling of the impact of a preconception care programme on congenital disorders","volume":"120","author":"Shannon","year":"2013","journal-title":"BJOG"},{"issue":"RR-14","key":"10.1016\/j.yebeh.2017.05.007_bb0015","first-page":"001","article-title":"Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","volume":"41","author":"CDC","year":"1992","journal-title":"MMWR"},{"issue":"01","key":"10.1016\/j.yebeh.2017.05.007_bb0020","first-page":"5","article-title":"Use of supplements containing folic acid among women of childbearing age - United States, 2007","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR"},{"issue":"3","key":"10.1016\/j.yebeh.2017.05.007_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-2008-1079337","article-title":"Teratogenicity of antiepileptic medications","volume":"28","author":"Kluger","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0030","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","author":"Tomson","year":"2015","journal-title":"Lancet Neurol"},{"issue":"21","key":"10.1016\/j.yebeh.2017.05.007_bb0035","first-page":"1692","article-title":"For the North American AED pregnancy registry","volume":"78","author":"Hernandez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2017.05.007_bb0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1586\/ern.10.57","article-title":"Teratogenic effects of antiepileptic drugs","volume":"10","author":"Hill","year":"2010","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1016\/j.yebeh.2017.05.007_bb0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2008.156109","article-title":"Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK epilepsy and pregnancy register","volume":"80","author":"Morrow","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.yebeh.2017.05.007_bb0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/pds.1975","article-title":"Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?","volume":"19","author":"Jentink","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2017.05.007_bb0065","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/epi.13320","article-title":"Contraceptive practices of women with epilepsy: findings of the epilepsy birth control registry","volume":"57","author":"Herzog","year":"2016","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2017.05.007_bb0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.fertnstert.2011.08.019","article-title":"Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States","volume":"96","author":"Xu","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/15246090050199982","article-title":"Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among health care providers","volume":"9","author":"Morrell","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"issue":"14","key":"10.1016\/j.yebeh.2017.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2011.1433","article-title":"Folic acid supplements in pregnancy and severe language delay in children","volume":"306","author":"Roth","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2017.05.007_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-3016.2009.01032.x","article-title":"Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort","volume":"23","author":"Julvez","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"3","key":"10.1016\/j.yebeh.2017.05.007_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years: a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017302846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017302846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T20:54:10Z","timestamp":1535748850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017302846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":20,"alternative-id":["S1525505017302846"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.007","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folic acid use by women with epilepsy: Findings of the Epilepsy Birth Control Registry","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}